↓ Skip to main content

New Directions in Affective Disorders

Overview of attention for book
Cover of 'New Directions in Affective Disorders'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Neurochemical and Behavioral Effects of Stress: A Rat Model of Depression
  3. Altmetric Badge
    Chapter 2 Study of Olfactory Bulbectomized Rats: Revelations About Major Depressive Disorder
  4. Altmetric Badge
    Chapter 3 Bilaterally Olfactory Bulbectomized Rat Model of Depression
  5. Altmetric Badge
    Chapter 4 Behavioral Despair: Past and Future
  6. Altmetric Badge
    Chapter 5 Genetically Nervous and Normal Pointer Dogs: Relation Between Hearing and Behavioral Abnormalities
  7. Altmetric Badge
    Chapter 6 Agonist-Induced Down-Regulation of β1-Adrenergic Receptors: Possible Biochemical Rationale for Novel Antidepressants
  8. Altmetric Badge
    Chapter 7 Behavioral Pharmacology and Clinical Antidepressant Effects of β-Adrenergic Agonists
  9. Altmetric Badge
    Chapter 8 Beyond Nosology in Biological Psychiatry: Prolegomena of a Functional Psychopathology
  10. Altmetric Badge
    Chapter 9 Serotonergic Aspects of Agonistic Behavior
  11. Altmetric Badge
    Chapter 10 Noradrenergic and Serotonergic Dysfunction in the Affective Disorders
  12. Altmetric Badge
    Chapter 11 Neuropeptides and Affective Disorders
  13. Altmetric Badge
    Chapter 12 Antemortem and Postmortem Measures of Central Nervous System Serotonergic Function: Methodological Issues
  14. Altmetric Badge
    Chapter 13 Postmortem Investigation of Serotonergic and Peptidergic Hypotheses of Affective Illness
  15. Altmetric Badge
    Chapter 14 Genetic Animal Model of Depression with Cholinergic Supersensitivity
  16. Altmetric Badge
    Chapter 15 Impact of the Cholinergic System on the Hypothalamic-Pituitary-Adrenocortical Axis and on REM Sleep
  17. Altmetric Badge
    Chapter 16 Relation Between m-Cholinoceptor Density on Human Blood Cells and Psychological Predisposition Factors for Depression
  18. Altmetric Badge
    Chapter 17 Differential Effects of Physostigmine in Alcoholics, Alcoholics with Affective Disorder, and Normal Individuals
  19. Altmetric Badge
    Chapter 18 Serotonin/Norepinephrine/Steroid Receptor Link in Brain and the Mode of Action of Antidepressants: Update and New Perspectives
  20. Altmetric Badge
    Chapter 19 Presynaptic Sites of Antidepressant Action: Monoamine Transport Systems and Release-Modulating Autoreceptors
  21. Altmetric Badge
    Chapter 20 Light-Dark-Related Changes in the Serotonin Uptake Molecular Complex in Rat Brain: Involvement in Antidepressant Action
  22. Altmetric Badge
    Chapter 21 Role of Serotonin (and Coexisting Peptides) in the Action Mechanism of Antidepressant Drugs
  23. Altmetric Badge
    Chapter 22 GABAB Receptors and Antidepressant Drugs
  24. Altmetric Badge
    Chapter 23 Antidepressants and Phospholipid Metabolism: β-Adrenoceptor Regulation in Cultured Human Cells
  25. Altmetric Badge
    Chapter 24 Nicotinic Effects of Antidepressants
  26. Altmetric Badge
    Chapter 25 Molecular Sites of Anxiolytic Action
  27. Altmetric Badge
    Chapter 26 Modulation of the Benzodiazepine/GABA Receptor Chloride Ionophore Complex: Evidence for an Asymmetrical Response of GABA-Gated Chloride Channels to Stress
  28. Altmetric Badge
    Chapter 27 Lithium Inhibition of Adenylate Cyclase Activity: Site of Action and Interaction with Divalent Cations
  29. Altmetric Badge
    Chapter 28 Comparison of the Effects of Lithium and Antidepressant Drugs on Second Messenger Systems in Rat Brain
  30. Altmetric Badge
    Chapter 29 Effects of Lithium Ions on the Metabolism of Phosphoinositides
  31. Altmetric Badge
    Chapter 30 Comparison of Theories of Lithium Action Based on Phosphatidylinositol Metabolism with Theories Based on Cyclic AMP
  32. Altmetric Badge
    Chapter 31 Serotonin and Catecholamines in Lithium Treatment
  33. Altmetric Badge
    Chapter 32 Lithium and Calcium Antagonists: Do They Act on One Neuronal Function?
  34. Altmetric Badge
    Chapter 33 Red Blood Cell Lithium Transport in Affective Illness: A Possible Mechanism of Action of Lithium
  35. Altmetric Badge
    Chapter 34 Selective Localization and Selective Inhibition of Monoamine Oxidase in Human Brain
  36. Altmetric Badge
    Chapter 35 Effect of Selective Monoamine Oxidase Substrates and Inhibitors on Lipid Peroxidation and Their Possible Involvement in Affective Disorders
  37. Altmetric Badge
    Chapter 36 Pharmacology of Monoamine Oxidase Inhibitors
  38. Altmetric Badge
    Chapter 37 Regulation of Functional Cytoplasmic Pool of Serotonin by MAO-A and MAO-B: Implications for Antidepressant Therapy
  39. Altmetric Badge
    Chapter 38 Neurochemical Profile of the Antidepressant Moclobemide, a Reversible Type A Monoamine Oxidase Inhibitor with Minimal Tyramine Potentiating Activity in Rats
  40. Altmetric Badge
    Chapter 39 Power of Genetic Linkage Studies for Heterogeneous Disorders
  41. Altmetric Badge
    Chapter 40 Single Locus Markers in Affective Disorders
  42. Altmetric Badge
    Chapter 41 One Form of Bipolar Affective Disorder is Mapped to Chromosome 11
  43. Altmetric Badge
    Chapter 42 X-Linkage Studies in Affective Disorders
  44. Altmetric Badge
    Chapter 43 Recombinant DNA Studies of X Linkage in Affective Disorders
  45. Altmetric Badge
    Chapter 44 Segregation Analysis in Families of Affective Patients Subdivided According to Treatment Outcome and Personality Disorders
  46. Altmetric Badge
    Chapter 45 Peripheral Blood Cell Biological Markers in Depression
  47. Altmetric Badge
    Chapter 46 α2-Adrenoceptors and Associated Functional Responses in Endogenous Depression
  48. Altmetric Badge
    Chapter 47 Neurotransmitters and Their Metabolites in CSF in Depression and Under the Influence of Antidepressant Drugs
  49. Altmetric Badge
    Chapter 48 High Affinity Imipramine Binding and Serotonin Uptake in Human Platelets as a Peripheral Biological Marker in Neuropsychiatric Disorders
  50. Altmetric Badge
    Chapter 49 Resting EEG as a Genetic Marker
  51. Altmetric Badge
    Chapter 50 EEG Sleep Changes in Recurrent Depression
  52. Altmetric Badge
    Chapter 51 Circadian and Ultradian Rhythms of 3-Methoxy-4-Hydroxyphenylglycol in Subtypes of Depressive Illness
  53. Altmetric Badge
    Chapter 52 Chronobiological Dysregulation of the Noradrenergic System in Depression
  54. Altmetric Badge
    Chapter 53 Diurnal Rhythm of Cortisol in Depression: What Is Normal and What Is Not
  55. Altmetric Badge
    Chapter 54 Circadian Rhythm Disturbances in Affective Disorders: Facts and Fictions
  56. Altmetric Badge
    Chapter 55 Pathophysiology of the Limbic-Hypothalamic-Pituitary-Adrenocortex System: An Overview
  57. Altmetric Badge
    Chapter 56 Neuroendocrine Dysfunctions in Affective Disorders: Effects of Clinical Changes
  58. Altmetric Badge
    Chapter 57 Preclinical and Clinical Investigations of Corticotropin-Releasing Factor: Assessment of Its Role in Depressive Disorders
  59. Altmetric Badge
    Chapter 58 Neuroendocrine Effects of Intravenous Ovine Corticotropin-Releasing Factor and Human Growth Hormone-Releasing Factor in Affective Disorder Patients and Normal Controls
  60. Altmetric Badge
    Chapter 59 TRH Stimulation Test in Psychiatry
  61. Altmetric Badge
    Chapter 60 Luteinizing Hormone and Prolactin Response to Buprenorphine in Depression and Schizophrenia
  62. Altmetric Badge
    Chapter 61 Neuroendocrine Factors in Antidepressant Drug Therapy
  63. Altmetric Badge
    Chapter 62 Neuroendocrine Studies of the Mechanism of Action of Antidepressant Drugs
  64. Altmetric Badge
    Chapter 63 Growth Hormone Response to Clonidine Stimulation in Affective Disorders: Effects of Lithium Therapy
  65. Altmetric Badge
    Chapter 64 Endocrinological Diseases Mimicking Affective Disorders
  66. Altmetric Badge
    Chapter 65 Epidemiology and Psychosocial Risk Factors for Suicide
  67. Altmetric Badge
    Chapter 66 Genetics and Suicidal Behavior in the Affective Disorders
  68. Altmetric Badge
    Chapter 67 Suicidal Behavior Among Children and Adolescents
  69. Altmetric Badge
    Chapter 68 Death Anxiety in a Psychiatric Population of Suicidal and Nonsuicidal Adolescents
  70. Altmetric Badge
    Chapter 69 Neurotransmitters and Neurotransmitter Receptors in Depressed Suicide Victims
  71. Altmetric Badge
    Chapter 70 Peripheral Serotonin and Catecholamine Levels and Suicidal Behavior
  72. Altmetric Badge
    Chapter 71 Past Suicide Attempt and Monoamine Metabolites: Comparing CSF Concentrations and Angularized Ratios
  73. Altmetric Badge
    Chapter 72 Affective Disorders During Childhood and Adolescence: Introduction
  74. Altmetric Badge
    Chapter 73 Study and Treatment of Childhood Depression as a Prototype for the Research and Conceptualization of Other Psychopathologies in Child Psychiatry
  75. Altmetric Badge
    Chapter 74 New Hypotheses of the Pharmacotherapy of Childhood and Adolescent Depression
  76. Altmetric Badge
    Chapter 75 Depression in Children: Defining the Therapeutic Range for Imipramine
  77. Altmetric Badge
    Chapter 76 Good Results with the Dexamethasone Suppression Test in Adolescent Inpatients: Implications for Diagnosis in Adolescent Psychiatry
  78. Altmetric Badge
    Chapter 77 Social Development of Children at High Risk for Depression: Preadolescence and Early Adolescence
  79. Altmetric Badge
    Chapter 78 Psychiatric Disorders in Children of Depressed Parents
  80. Altmetric Badge
    Chapter 79 Diagnostic Criteria for Depression in Alzheimer’s Disease
  81. Altmetric Badge
    Chapter 80 Association of Somatic Disease with Affective Disorders in Middle and Old Age
  82. Altmetric Badge
    Chapter 81 Excess Mortality in Late Life Depression
  83. Altmetric Badge
    Chapter 82 Adverse Effects of Antidepressant Drugs in the Elderly
  84. Altmetric Badge
    Chapter 83 Menarche and Menstrual Symptoms: Psychosocial Perspectives
  85. Altmetric Badge
    Chapter 84 Affect and Nurturance in First-Time Mothers: Role of Psychobiological Influences
  86. Altmetric Badge
    Chapter 85 Myth of Menopausal Depression
  87. Altmetric Badge
    Chapter 86 Epinephrine-Induced Anxiety and Regional Cerebral Blood Flow in Anxious Patients
  88. Altmetric Badge
    Chapter 87 Neurobiological Mechanisms of Panic Anxiety: Review of the Behavioral, Biochemical, and Cardiovascular Effects of Three Panicogenic Stimuli
  89. Altmetric Badge
    Chapter 88 Caffeine Model of Panic
  90. Altmetric Badge
    Chapter 89 Pharmacological Treatment of Panic Disorders
  91. Altmetric Badge
    Chapter 90 Heterogeneity and Coexistence in DSM-III-R Obsessive Compulsive Disorder
  92. Altmetric Badge
    Chapter 91 Applicability of Models of Anxiety to Obsessive Compulsive Disorder
  93. Altmetric Badge
    Chapter 92 Frontal Lobe Involvement in Obsessive Compulsive Disorder: Electroencephalographic Evidence
  94. Altmetric Badge
    Chapter 93 Pharmacological Treatment of Obsessive Compulsive Disorder
  95. Altmetric Badge
    Chapter 94 Use of Antiandrogens in the Treatment of Obsessive Compulsive Disorders: Theoretical Considerations
  96. Altmetric Badge
    Chapter 95 Psychobiology of the Trauma Response
  97. Altmetric Badge
    Chapter 96 Psychophysiology of Posttraumatic Stress Disorder
  98. Altmetric Badge
    Chapter 97 From CSR to PTSD
  99. Altmetric Badge
    Chapter 98 Social Support Versus Self-Sufficiency in Traumatic and Posttraumatic Stress Reactions
  100. Altmetric Badge
    Chapter 99 Pharmacotherapy Trials in Posttraumatic Stress Disorder: Prospects and Problems
  101. Altmetric Badge
    Chapter 100 Psychobiology of Dissociation
  102. Altmetric Badge
    Chapter 101 Eating Disorder and Affective Disorder: How Real Is the Relation?
  103. Altmetric Badge
    Chapter 102 Neuroendocrine Findings in Depression, Anorexia Nervosa, and Bulimia
  104. Altmetric Badge
    Chapter 103 Antidepressant Therapies for Treatment of Anorexia Nervosa and Bulimia Nervosa
  105. Altmetric Badge
    Chapter 104 Psychodynamic Reflections on Anorexia Nervosa
  106. Altmetric Badge
    Chapter 105 Schizoaffective Psychoses: Six Hypotheses
  107. Altmetric Badge
    Chapter 106 Psychopharmacology of Schizoaffective Mania
  108. Altmetric Badge
    Chapter 107 Neuroendocrinology of Schizoaffective Disorders
  109. Altmetric Badge
    Chapter 108 Prophylaxis of Schizoaffective Disorders
  110. Altmetric Badge
    Chapter 109 Treatment of Depression in Schizophrenia
  111. Altmetric Badge
    Chapter 110 Pharmacotherapy and the Overlap Between Affective and Other Psychiatric Disorders
  112. Altmetric Badge
    Chapter 111 Classification of Affective Disorders and Psychopharmacology: Rosetta Stone or Hypothetical Construct?
  113. Altmetric Badge
    Chapter 112 Diagnostic Dimensions of the Newcastle Scales and the Response to Antidepressant Treatments
  114. Altmetric Badge
    Chapter 113 Mode of Action of Anticonvulsants in Affective Illness
  115. Altmetric Badge
    Chapter 114 Acute and Prophylactic Properties of Carbamazepine in Bipolar Affective Disorders
  116. Altmetric Badge
    Chapter 115 Use of Carbamazepine in Affective Illness
  117. Altmetric Badge
    Chapter 116 Action of Carbamazepine Suspension in Acute Manic Syndromes
  118. Altmetric Badge
    Chapter 117 Carbamazepine in the Long-Term Treatment of Affective Disorders: Research Strategies
  119. Altmetric Badge
    Chapter 118 Plasma Levels of Carbamazepine in Affective Disorder
  120. Altmetric Badge
    Chapter 119 Efficacy and Safety of Lithium-Carbamazepine Combination in Mania
  121. Altmetric Badge
    Chapter 120 Patient Characteristics and Factors Associated with Chronic Depression and Its Treatment
  122. Altmetric Badge
    Chapter 121 Resistant Depression: Clinical Characteristics and Response to Treatment
  123. Altmetric Badge
    Chapter 122 Clinical Indicators in Resistant Depressions
  124. Altmetric Badge
    Chapter 123 Combined MAO Inhibitor and Tri/Tetracyclic Antidepressant Treatment in Therapy-Resistant Depression
  125. Altmetric Badge
    Chapter 124 Management of Resistant Major Depression
  126. Altmetric Badge
    Chapter 125 Clinical Characteristics of Placebo Response in Depression
  127. Altmetric Badge
    Chapter 126 Pretreatment Pituitary-Adrenocortical Status: Prediction of Placebo Response in Depression
  128. Altmetric Badge
    Chapter 127 Clinical Features, DST, and Response to Placebo in Depressed Outpatients
  129. Altmetric Badge
    Chapter 128 Antidepressant Drug Measurement: Review of Methods for Clinical Application
  130. Altmetric Badge
    Chapter 129 Relation Between Plasma Antidepressant Concentrations and Clinical Effects
  131. Altmetric Badge
    Chapter 130 Clinical Implications of the Tricyclic Antidepressant Hydroxy-Metabolites
  132. Altmetric Badge
    Chapter 131 Disposition and Effects of E-10-Hydroxynortriptyline—An Active Metabolite of Nortriptyline
  133. Altmetric Badge
    Chapter 132 Genetic Polymorphism in Drug Oxidation: Implications for the Clinical Use of Tricyclic Antidepressants
  134. Altmetric Badge
    Chapter 133 Overdosage of Antidepressants
  135. Altmetric Badge
    Chapter 134 Risk-Benefit Assessment of Deaths from Adverse Drug Reactions and Overdosage with Antidepressants
  136. Altmetric Badge
    Chapter 135 Assessing the Safety of Antidepressant Drugs After Marketing: A U.S. View
  137. Altmetric Badge
    Chapter 136 Tricyclic Antidepressants, Electroconvulsive Therapy, and Memory in Depressed Patients
  138. Altmetric Badge
    Chapter 137 GABA Theory of Depression and Antidepressant Drug Action
  139. Altmetric Badge
    Chapter 138 GABA-Mimetic Agent Fengabine in the Treatment of Depression: An Overview
  140. Altmetric Badge
    Chapter 139 Antidepressant Activity of Progabide and Fengabine
  141. Altmetric Badge
    Chapter 140 Activity of Fengabine, a GABAergic Drug, in Depression
  142. Altmetric Badge
    Chapter 141 Depression in Children and Adolescents: A Controlled Study of Progabide Versus Imipramine
  143. Altmetric Badge
    Chapter 142 Electrode Placement and Stimulus Waveform: Conceptual and Practical Issues
  144. Altmetric Badge
    Chapter 143 Unilateral and Bilateral Electroconvulsive Therapy in Depressive Illness
  145. Altmetric Badge
    Chapter 144 ECT: Rising Trends and Current Policy
  146. Altmetric Badge
    Chapter 145 Pharmacological Manipulation of Seizure Duration: A New Direction in ECT Technology
  147. Altmetric Badge
    Chapter 146 “Isoflurane Narcotherapy” in Depression: Methodological Issues
  148. Altmetric Badge
    Chapter 147 Response to Combined Pharmacotherapy and Psychotherapy Among Recurrent Depressives
  149. Altmetric Badge
    Chapter 148 Cognitive Therapy for Major Depressive Disorder: Current Status
  150. Altmetric Badge
    Chapter 149 Use of Reminiscing in the Psychotherapy of Depression
Attention for Chapter 27: Lithium Inhibition of Adenylate Cyclase Activity: Site of Action and Interaction with Divalent Cations
Altmetric Badge

Mentioned by

twitter
3 X users

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Lithium Inhibition of Adenylate Cyclase Activity: Site of Action and Interaction with Divalent Cations
Chapter number 27
Book title
New Directions in Affective Disorders
Published by
Springer New York, January 1989
DOI 10.1007/978-1-4612-3524-8_27
Book ISBNs
978-0-387-96769-1, 978-1-4612-3524-8
Authors

A. Mørk, A. Geisler, Mørk, A., Geisler, A.

Editors

Bernard Lerer M.D., Samuel Gershon M.D.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 100%
Readers by discipline Count As %
Physics and Astronomy 1 100%